Examkin

Soru

Zorluk: OrtaMenstrual Cycle Abnormalities and Contraception

During a comprehensive family planning clinic session, four patients present for contraceptive counseling. Based on the United States Medical Eligibility Criteria (US MEC) for Contraceptive Use, match each patient's clinical profile with the most appropriate contraceptive method.

  • A 37-year-old woman who smokes 20 cigarettes daily and strongly prefers a daily oral medicationNorethindrone oral tablet
  • A 32-year-old woman with a history of estrogen-receptor-positive breast cancer, currently taking tamoxifenCopper-containing intrauterine device
  • A 28-year-old woman with obesity, heavy menstrual bleeding, and severe baseline dysmenorrheaLevonorgestrel-releasing intrauterine device
  • A 24-year-old woman taking carbamazepine for epilepsy who desires a long-acting, non-intrauterine contraceptiveDepot medroxyprogesterone acetate injection

Cevap

Match the 37-year-old smoker with the Norethindrone oral tablet; the 32-year-old with breast cancer with the Copper-containing intrauterine device; the 28-year-old with heavy bleeding with the Levonorgestrel-releasing intrauterine device; and the 24-year-old taking carbamazepine with the Depot medroxyprogesterone acetate injection.
Each patient possesses specific medical conditions or preferences that dictate contraceptive safety and efficacy according to the US MEC guidelines. Estrogen is strictly avoided in older smokers, all hormones are strictly avoided in breast cancer patients, levonorgestrel intrauterine devices are uniquely indicated for treating heavy menstrual bleeding, and depot medroxyprogesterone acetate is safe and effective when used alongside CYP450 inducers.

Adım Adım Çözüm

1
Evaluate the 37-year-old smoker's profile.
Identify an absolute contraindication to estrogen-containing methods.
Smoking 15 or more cigarettes per day at age 35 or older significantly increases the risk of myocardial infarction and ischemic stroke with estrogen use. She requires a progestin-only oral method.
2
Evaluate the 32-year-old with a history of breast cancer.
Rule out all hormonal contraceptive methods.
A history of breast cancer is a US MEC category 4 risk for all estrogen- and progestin-containing methods. A non-hormonal copper intrauterine device is required.
3
Evaluate the 28-year-old with heavy menstrual bleeding.
Select a method that offers therapeutic benefits for heavy bleeding.
The levonorgestrel-releasing intrauterine device thins the endometrium locally, making it the most appropriate option to simultaneously provide contraception and manage her menorrhagia and dysmenorrhea.
4
Evaluate the 24-year-old taking a CYP450-inducing antiepileptic drug.
Select a method unaffected by hepatic enzyme induction.
Carbamazepine reduces the efficacy of oral pills and progestin implants. DMPA injections and intrauterine devices are not clinically affected by CYP inducers, and DMPA aligns with her preference for a non-intrauterine method.

Anahtar Kavram

Application of the United States Medical Eligibility Criteria (US MEC) for contraception, specifically recognizing contraindications to estrogen (age >35 and smoking), absolute contraindications to all hormones (breast cancer), non-contraceptive benefits (LNG-IUD for heavy bleeding), and the impact of hepatic enzyme inducers on hormonal metabolism.
Bu soruyu puanla

Konular

Menstrual Cycle Abnormalities and Contraception

Bu konudan daha fazla soru